Natera sues ArcherDX for oncology patent infringement
29-01-2020
English High Court upholds Sequenom patent for prenatal test
18-06-2019
Jarun Ontakrai/ Shutterstock.com
Natera has agreed to license Illumina IP covering non-invasive prenatal testing (NIPT), in a deal that sees the pair settle all outstanding patent litigation over the technology.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Natera, Illumina, prenatal, testing, patent, infringement, licence, litigation, settle, agree, sequencing, platform, NPIT
